% Expired Patents = 66.7

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 6

Loading Chart...

7 inventors (with patents filed for the assignee):

Mark Brian Pepys (9 out of 13 patents)

Steven Victor Ley (1 out of 6 patents)

Vittorio Bellotti (1 out of 1 patent)

4. Angus John Morrison (1 out of 1 patent)

5. Simon Kolstoe (1 out of 1 patent)

6. Martin Smith (1 out of 1 patent)

7. Philip Nigel Hawkins (1 out of 1 patent)

8. Mark B Pepys (0 patent)

9 patents: Sort by Forward Citations

1. 9192668 - Combinations of SAP depleting agents and anti-SAP antibodies (2015-11-24),

2. 8236984 - Compound and use thereof in the treatment of amyloidosis (2012-08-07),

3. 8173694 - Therapeutic agent (2012-05-08),

4. 8039222 - Treatment and prevention of tissue damage (2011-10-18),

5. 7910106 - Combinations of SAP depleting agents and anti-SAP antibodies (2011-03-22),

6. 7691897 - Therapeutic agent (2010-04-06),

7. 7659299 - Compounds inhibiting the binding of sap for treating osteoarthritis (2010-02-09),

8. 7615543 - Treatment and prevention of tissue damage (2009-11-10),

9. 7390795 - Treatment and prevention of tissue damage (2008-06-24),

Company Overview

Pentraxin Therapeutics Limited is a biopharmaceutical company dedicated to developing innovative therapies for inflammatory and autoimmune diseases. With a focus on utilizing the power of pentraxin proteins, the company is committed to advancing novel treatments that address unmet medical needs. Through strategic partnerships and a strong pipeline of drug candidates, Pentraxin Therapeutics is poised to make a significant impact in the field of immunology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#348 in London

#1,902 in United Kingdom

London, United Kingdom

Pentraxin Therapeutics Limited

Forward Citations = 6

7 inventors:

Mark Brian Pepys (9 out of 13 patents)

Steven Victor Ley (1 out of 6 patents)

Vittorio Bellotti (1 out of 1 patent)

4. Angus John Morrison (1 out of 1 patent)

5. Simon Kolstoe (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pentraxin Therapeutics Limited. Retrieved from https://idiyas.com/company/pentraxin-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]